HEATHER Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Heather, and what generic alternatives are available?
Heather is a drug marketed by Glenmark Generics and is included in one NDA.
The generic ingredient in HEATHER is norethindrone. There are twenty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the norethindrone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Heather
A generic version of HEATHER was approved as norethindrone by GLENMARK GENERICS on July 22nd, 2010.
Summary for HEATHER
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 76 |
Clinical Trials: | 2 |
Patent Applications: | 3,777 |
Formulation / Manufacturing: | see details |
Drug Sales Revenues: | Drug sales revenues for HEATHER |
DailyMed Link: | HEATHER at DailyMed |
Recent Clinical Trials for HEATHER
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of California, San Francisco | Phase 4 |
Emory University | N/A |
Bristol-Myers Squibb | N/A |
Pharmacology for HEATHER
Drug Class | Progestin |
US Patents and Regulatory Information for HEATHER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glenmark Generics | HEATHER | norethindrone | TABLET;ORAL-28 | 090454-001 | Apr 23, 2010 | AB1 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |